Latent Health builds a clinical AI platform that helps large hospital systems get patients their medications faster. The core problem it solves: prior authorization — the process where physicians must document why a patient needs a specific drug and submit it to an insurer for approval — is paper-heavy, slow, and fails patients in 42% of critical cases. Latent reads a patient's electronic health record (EHR), extracts the relevant clinical evidence, generates the required documentation, and automates submission and appeals workflows. It also handles 340B drug discount compliance and pharmacy operations. The buyers are health system pharmacy and clinical operations teams; the pitch is fewer FTEs needed, faster time-to-therapy, and more revenue captured for the pharmacy. Latent now serves 50+ health systems — including Yale New Haven, UCSF, Vanderbilt, Mount Sinai, Ochsner, and UCLA — and reaches over 2 million patients annually. The company positions itself as "pharmacy intelligence infrastructure," targeting the $200B specialty drug market.